Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Saudi Arabia Synthetic Biology Market: Industry Trends and Global Forecasts - Distribution by Type of Product, Type of Tool, Type of Technology, Type of Application, End User and Leading Players" report has been added to ResearchAndMarkets.com's offering.
The Saudi Arabia synthetic biology market is estimated to grow from USD 200 million in the current year to USD 980 million by 2035 at a CAGR of 14.1% during the forecast period, till 2035.
Synthetic biology involves the intentional design of biological systems through various molecular technologies and tools to develop medicines and other bio-based products. The synthetic biology industry is experiencing significant growth driven by the rising utilization of targeted treatments, biologics, and products derived from biology. This field enables the development of tailored organisms, giving pharmaceutical companies the ability to design vaccines, semi-synthetic drugs, and gain insights into disease mechanisms.
In addition to pharmaceuticals, there is a significant increase in interest for synthetic biology within the biotechnology industry and agriculture industries. Additionally, the continuous transition to biofuels or green fuels and the increasing need for sustainable or biodegradable goods have propelled market growth. With the advancement of synthetic biology technologies in different industrial sectors, the synthetic biology solution providers are facilitating the development of sustainable bio-based solutions. Additionally, advancements in synthetic biology are broadening their applications as tools for the writing, reading, and alteration of DNA in organisms to produce valuable products.
Notably, the synthetic biology market in Saudi Arabia is also undergoing rapid expansion as part of the Kingdom's Vision 2030 strategy to diversify its economy beyond oil into high-tech sectors like biotechnology. This growth is propelled by massive government investments, including billions allocated through the Saudi Human Genome Program and the National Center for Biotechnology, which have poured over $3.9 billion into R&D in recent years to foster biotech self-sufficiency in this sector within the region.
Growth Drivers: Strategic Enablers of Market Expansion
Saudi Arabia's synthetic biology industry is witnessing investments in billions in biotech infrastructure and establishing the region as a prominent innovator in the field. The national framework in Saudi Arabia focuses on reducing dependence on oil by promoting knowledge-based industries, highlighting the importance of syn-bio technologies like CRISPR gene editing for creating drought-resistant crops and bioengineered microbes for food production in arid regions. Further, collaborative efforts with international companies, coupled with increased funding in genomic tools, PCR technologies, and bioprocessing are likely to contribute to high market growth in the region.
Market Challenges: Critical Barriers Impeding Progress
Despite encouraging support, Saudi Arabia's synthetic biology sector faces fundamental challenges that slows its swift progress. Regulatory uncertainties persist as frameworks for gene-edited products and bio fabrication fail to keep pace with international standards, obstructing market entry and timelines for commercialization.
Further, elevated R&D expenses, along with a lack of specialized local skills in bioinformatics and metabolic engineering, compel dependence on international talent and collaborations, putting pressure on emerging infrastructure such as biomanufacturing plants. In addition, protection for intellectual property remain inadequate, and shortcomings in state-of-the-art laboratories and supply chains exacerbate vulnerabilities, highlighting the need for strategic alignment with national policies to fully capitalize on opportunities during economic transitions.
Polymerase Chain Reaction (PCR): Leading Market Segment
In terms of type of technology, the Saudi Arabia synthetic biology market is categorized into PCR technology, NGS technology, genome editing technology, bioprocessing technology, and additional technologies. At present, the polymerase chain reaction (PCR) segment holds the largest share of the overall market share, owing to its accuracy, speed, and widespread application in detecting infectious diseases, genetic disorders, and cancer. The genome editing technology sector is expected to expand at a higher CAGR throughout the forecast period, driven by its ability to provide intricate genomic information.
Oligonucleotide / Oligo Pools and Synthetic DNA: Dominating Market Segment
In terms of type of product, the Saudi Arabia Synthetic biology market is segmented across oligonucleotide / oligo pools and synthetic DNA, enzymes, cloning technologies kits, chassis organism, and others. At present, the largest market share is occupied by oligonucleotide / oligo pools and synthetic DNA. This can be attributed to the gathering of blood, serum, and plasma in clinical settings, enabling extensive testing and continuous monitoring. Moreover, the urine segment is anticipated to witness a greater compound annual growth rate (CAGR) during the forecast period.
Academic and Government Research Institutes: Emerging Market Segment
In terms of end-users, the Saudi Arabia Synthetic biology market is segmented across biotechnology and pharmaceutical companies, academic and government research institutes and others. Currently, majority of the market share is held by biotechnology and pharmaceutical companies. However, academic and government research institutes are anticipated to grow at a higher CAGR.
Reasons to Buy this Report
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
- The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
- The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
- The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
- The report allows for more effective communication with the audience and in building strong business relations.
Saudi Arabia Synthetic biology Market: Key Segments
Type of Product
- Core Products
- Enabling Products
Type of Tool
- Oligonucleotides and Synthetic DNA
- Enzymes
- Cloning Technology Kits
- Synthetic Cells
Type of Technology
- Gene Synthesis
- Genome Engineering
- Microfluidics
- Nanotechnology
- Sequencing
- Bioinformatics
- Site-Directed Mutagenesis
- Cloning
- Measurement and Modeling
- Polymerase Chain Reaction
Type of Application
- Healthcare
- Artificial Tissue & Tissue Regeneration
- Industrial
- Environmental
- Food
- Agriculture
End User
- Biotechnology and Pharmaceutical companies
- Academic and Research Institutes
- Other End Users
Example Players in the Saudi Arabia Synthetic Biology Market
- BASF SE
- Codexis
- Eurofins Scientific
- Illumina
- Merck KGaA
- New England Biolabs
- Novozyme
- Synthego
- Thermo Fisher Scientific
Complementary Benefits
- Complimentary Excel Data Packs Covering All Analytical Modules
- Up to 15% Complimentary Content Customization
- In-Depth Report Walkthrough with the Research Team
- Complimentary Report Update if the Report is 6+ Months Old
For more information about this report visit https://www.researchandmarkets.com/r/a4xct9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
